4169.TWO
Price:
$50.5
Market Cap:
$2.98B
TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases. The company's products include osteoarthritis treatment products, osteoporosis treatment preparations, iron supplement, urinary system treatment products, expectorants/mucolytic agents, anti-hypertensive preparations, and anti-diabetic preparations, anti-adhesion systems, pellefeel wound care systems, Philips non-invasive ventilators, and others, as well as medical devices and functional foods. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.
Industry
Drug Manufacturers - General
IPO Date
2012-06-20
Stock Exchange
TWO
Ticker
4169.TWO
According to TCM Biotech International Corp.’s latest financial reports and current stock price. The company's current PE Ratio is 140.28. This represents a change of 64.45% compared to the average of 85.30 of the last 4 quarters.
The mean historical PE Ratio of TCM Biotech International Corp. over the last ten years is 268.33. The current 140.28 PE Ratio has changed 5.13% with respect to the historical average. Over the past ten years (40 quarters), 4169.TWO's PE Ratio was at its highest in in the December 2021 quarter at 487.86. The PE Ratio was at its lowest in in the June 2020 quarter at 24.01.
Average
268.33
Median
161.16
Minimum
67.06
Maximum
975.72
Discovering the peaks and valleys of TCM Biotech International Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.35%
Maximum Annual PE Ratio = 975.72
Minimum Annual Increase = -91.92%
Minimum Annual PE Ratio = 67.06
Year | PE Ratio | Change |
---|---|---|
2024 | 162.73 | -1.97% |
2023 | 166.00 | 110.47% |
2022 | 78.87 | -91.92% |
2021 | 975.72 | 1.35% |
2020 | 67.06 | -57.98% |
The current PE Ratio of TCM Biotech International Corp. (4169.TWO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
135.87
5-year avg
290.08
10-year avg
268.33
TCM Biotech International Corp.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TCM Biotech International Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TCM Biotech International Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is TCM Biotech International Corp.'s PE Ratio?
How is the PE Ratio calculated for TCM Biotech International Corp. (4169.TWO)?
What is the highest PE Ratio for TCM Biotech International Corp. (4169.TWO)?
What is the 3-year average PE Ratio for TCM Biotech International Corp. (4169.TWO)?
What is the 5-year average PE Ratio for TCM Biotech International Corp. (4169.TWO)?
How does the current PE Ratio for TCM Biotech International Corp. (4169.TWO) compare to its historical average?